The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $32.26

Today's change-1.19 -3.56%
Updated February 9 1:05 PM EST. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $32.26

Today's change-1.19 -3.56%
Updated February 9 1:05 PM EST. Delayed by at least 15 minutes.

NU Skin Enterprises Inc down (U.S.)$1.19

NU Skin Enterprises Inc is sharply lower today, dropping (U.S.)$1.19 or 3.56% to (U.S.)$32.26. Over the last five days, shares have gained 3.03%, but are down 14.86% for the last year to date. Shares have underperformed the S&P 500 by 30.92% during the last year.

Key company metrics

  • Open(U.S.) $33.10
  • Previous close(U.S.) $33.45
  • High(U.S.) $33.64
  • Low(U.S.) $32.25
  • Bid / Ask(U.S.) $32.25 / (U.S.) $32.29
  • YTD % change-14.86%
  • Volume358,035
  • Average volume (10-day)958,735
  • Average volume (1-month)1,015,328
  • Average volume (3-month)1,300,837
  • 52-week range(U.S.) $29.52 to (U.S.) $62.87
  • Beta1.36
  • Trailing P/E13.47×
  • P/E 1 year forward11.56×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield4.34%
  • Trailing EPS(U.S.) $2.40
Updated February 9 1:05 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.29%

Based on its net profit margin of 6.29%, NU Skin Enterprises Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.52%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue571560543610
Total other revenue--------
Total revenue571560543610
Gross profit419450438503
Total cost of revenue153110105107
Total operating expense529488475518
Selling / general / administrative376378370412
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income43726991
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax28695675
Income after tax16453647
Income tax, total12242029
Net income16453647
Total adjustments to net income--------
Net income before extra. items16453647
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items16453647
Inc. avail. to common incl. extra. items16453647
Diluted net income16453647
Dilution adjustment--------
Diluted weighted average shares59606061
Diluted EPS excluding extraordinary itemsvalue per share0.280.750.600.77
Dividends per sharevalue per share0.350.350.350.35
Diluted normalized EPSvalue per share0.280.750.600.77